Inventor · disambiguated record
Jonathan Powell
Also filed as: POWELL JONATHAN · POWELL JONATHAN D · POWELL JONATHAN DAVID · POWELL JONATHAN RICHARD
5 granted patents·6 pending applications·18 citations·filing 2003–2024
73Inventor score
Top patents by PatentIndex Score
11 records- 0192US10568868B2Methods and compositions for treating metabolic reprogramming disordersUNIV JOHNS HOPKINS·Filed 2018·Granted Feb 25, 2020·8 cites·19 claims
- 0291US10842763B2Methods for cancer and immunotherapy using prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2019·Granted Nov 24, 2020·8 cites·16 claims
- 0371US10034924B2Methods and compositions for enhanced cellular selectivity using nanocarrier-associated ligandsUNIV JOHNS HOPKINS·Filed 2014·Granted Jul 31, 2018·2 cites·38 claims
- 0466US11759444B2Methods for cancer and immunotherapy using prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2020·Granted Sep 19, 2023·0 cites·19 claims
- 0558US2024408114A1Methods for preventing and treating acute kidney injuryUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 0656US2024226156A1Anti-fibrotic tissue resident memory t cells and uses thereofUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 0751US2023218581A1Compositions and methods comprising dendrimers and therapeutic agentsUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 0845US11103486B2Treatment of autoimmune disorders and infections using antagonists of SGK1 activityUNIV JOHNS HOPKINS·Filed 2016·Granted Aug 31, 2021·0 cites·4 claims
- 0941US2004054265A1Psychological stress in humansCONOPCO INC·Filed 2003·Application pending·0 cites
- 1037US2014120111A1Treatment of autoimmune disorders and infections using antagonists of sgk1 activityUNIV JOHNS HOPKINS·Filed 2012·Application pending·0 cites
- 1135US2014205578A1Methods for increasing insulin sensitivity and treating diabetesPOWELL JONATHAN D·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Powell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →